Safety Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data Author Name Joseph A. Lasky et al Category Computer science, information & general works Type Journal Tags Interstitial lung diseases,Monitoring,drug,Postmarketing drug surveillance,Tyrosine kinase inhibitor Login to Access Content
